Immunoproteomically identified GBAA_0345, alkyl hydroperoxide reductase subunit C is a potential target for multivalent anthrax vaccine
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Yeon Hee | - |
dc.contributor.author | Kim, Kyung Ae | - |
dc.contributor.author | Kim, Yu-Ri | - |
dc.contributor.author | Choi, Min Kyung | - |
dc.contributor.author | Kim, Hye Kyeong | - |
dc.contributor.author | Choi, Ki Ju | - |
dc.contributor.author | Chun, Jeong-Hoon | - |
dc.contributor.author | Cha, Kiweon | - |
dc.contributor.author | Hong, Kee-Jong | - |
dc.contributor.author | Lee, Na Gyong | - |
dc.contributor.author | Yoo, Cheon-Kwon | - |
dc.contributor.author | Oh, Hee-Bok | - |
dc.contributor.author | Kim, Tae Sung | - |
dc.contributor.author | Rhie, Gi-eun | - |
dc.date.accessioned | 2021-09-05T12:48:20Z | - |
dc.date.available | 2021-09-05T12:48:20Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-01 | - |
dc.identifier.issn | 1615-9853 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/99704 | - |
dc.description.abstract | Anthrax is caused by the spore-forming bacterium Bacillus anthracis, which has been used as a weapon for bioterrorism. Although current vaccines are effective, they involve prolonged dose regimens and often cause adverse reactions. High rates of mortality associated with anthrax have made the development of an improved vaccine a top priority. To identify novel vaccine candidates, we applied an immunoproteomics approach. Using sera from convalescent guinea pigs or from human patients with anthrax, we identified 34 immunogenic proteins from the virulent B. anthracisH9401. To evaluate vaccine candidates, six were expressed as recombinant proteins and tested in vivo. Two proteins, rGBAA_0345 (alkyl hydroperoxide reductase subunit C) and rGBAA_3990 (malonyl CoA-acyl carrier protein transacylase), have afforded guinea pigs partial protection from a subsequent virulent-spore challenge. Moreover, combined vaccination with rGBAA_0345 and rPA (protective antigen) exhibited an enhanced ability to protect against anthrax mortality. Finally, we demonstrated that GBAA_0345 localizes to anthrax spores and bacilli. Our results indicate that rGBAA_0345 may be a potential component of a multivalent anthrax vaccine, as it enhances the efficacy of rPA vaccination. This is the first time that sera from patients with anthrax have been used to interrogate the proteome of virulent B. anthracis vegetative cells. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY-BLACKWELL | - |
dc.subject | RECOMBINANT PROTECTIVE ANTIGEN | - |
dc.subject | BACILLUS-ANTHRACIS | - |
dc.subject | COMPARATIVE EFFICACY | - |
dc.subject | CONFERS PROTECTION | - |
dc.subject | SUBOPTIMAL AMOUNTS | - |
dc.subject | PROTEOMIC ANALYSIS | - |
dc.subject | SPORE CHALLENGE | - |
dc.subject | PROTEINS | - |
dc.subject | CANDIDATES | - |
dc.subject | IMMUNOGENICITY | - |
dc.title | Immunoproteomically identified GBAA_0345, alkyl hydroperoxide reductase subunit C is a potential target for multivalent anthrax vaccine | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Tae Sung | - |
dc.identifier.doi | 10.1002/pmic.201200495 | - |
dc.identifier.scopusid | 2-s2.0-84892425086 | - |
dc.identifier.wosid | 000330727000011 | - |
dc.identifier.bibliographicCitation | PROTEOMICS, v.14, no.1, pp.93 - 104 | - |
dc.relation.isPartOf | PROTEOMICS | - |
dc.citation.title | PROTEOMICS | - |
dc.citation.volume | 14 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 93 | - |
dc.citation.endPage | 104 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biochemical Research Methods | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.subject.keywordPlus | RECOMBINANT PROTECTIVE ANTIGEN | - |
dc.subject.keywordPlus | BACILLUS-ANTHRACIS | - |
dc.subject.keywordPlus | COMPARATIVE EFFICACY | - |
dc.subject.keywordPlus | CONFERS PROTECTION | - |
dc.subject.keywordPlus | SUBOPTIMAL AMOUNTS | - |
dc.subject.keywordPlus | PROTEOMIC ANALYSIS | - |
dc.subject.keywordPlus | SPORE CHALLENGE | - |
dc.subject.keywordPlus | PROTEINS | - |
dc.subject.keywordPlus | CANDIDATES | - |
dc.subject.keywordPlus | IMMUNOGENICITY | - |
dc.subject.keywordAuthor | Bacillus anthracis | - |
dc.subject.keywordAuthor | Immunoproteomics | - |
dc.subject.keywordAuthor | Alkyl hydroperoxide reductase subunit C | - |
dc.subject.keywordAuthor | Microbiology | - |
dc.subject.keywordAuthor | Vaccine | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.